SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-029142
Filing Date
2012-05-15
Accepted
2012-05-15 11:39:30
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v312357_10-q.htm 10-Q 327304
2 EXHIBIT 31.1 v312357_ex31-1.htm EX-31.1 7232
3 EXHIBIT 31.2 v312357_ex31-2.htm EX-31.2 7519
4 EXHIBIT 32.1 v312357_ex32-1.htm EX-32.1 4575
5 EXHIBIT 32.2 v312357_ex32-2.htm EX-32.2 4352
  Complete submission text file 0001144204-12-029142.txt   1463043

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20120331.xml EX-101.INS 87656
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20120331.xsd EX-101.SCH 12702
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20120331_cal.xml EX-101.CAL 37317
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20120331_def.xml EX-101.DEF 87866
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20120331_lab.xml EX-101.LAB 124942
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20120331_pre.xml EX-101.PRE 103873
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 12842265
SIC: 2836 Biological Products, (No Diagnostic Substances)